Sudafed Daily Dosage
For adults and children 12 years and older, the recommended dose is 60 mg every 4-6 hours, not exceeding 240 mg in 24 hours; for children aged 6-12 years, the dose is 30 mg every 4-6 hours, not exceeding 120 mg in 24 hours. 1
Adult Dosing (≥12 years)
The FDA-approved dosing for pseudoephedrine in adults is straightforward: take 1 caplet (60 mg) every 4 hours while symptoms persist, with a maximum of 6 caplets (360 mg) in 24 hours 1. However, clinical evidence supports that 60 mg is the optimal single adult dose, achieving maximal nasal decongestion without cardiovascular effects 2. Higher doses (120 mg and 180 mg) produce small but statistically significant increases in pulse and systolic blood pressure without additional decongestant benefit 2.
The practical daily maximum should be 240 mg (60 mg four times daily) rather than the labeled 360 mg, as doses above 60 mg per administration offer no additional efficacy but increase cardiovascular risks 2.
Pediatric Dosing (6-12 years)
Children aged 6-12 years should receive 30 mg every 4-6 hours as needed, not exceeding 120 mg in 24 hours 3. This dosing is supported by a multicenter randomized controlled trial demonstrating that pseudoephedrine 30 mg provides temporary relief of nasal congestion in children 6 to <12 years of age 3. The pharmacokinetic profile in children shows a shorter elimination half-life (3.1 ± 0.5 hours) compared to adults, supporting the 4-6 hour dosing interval 4.
Critical Safety Considerations
Children Under 6 Years
Do not use pseudoephedrine in children under 6 years of age 1. The FDA labeling explicitly states this product contains too much medication for children under 12 years 1. Use in infants and young children has been associated with serious adverse events including agitated psychosis, ataxia, hallucinations, and even death 5.
Cardiovascular Monitoring
While blood pressure elevation is rarely noted in normotensive patients, patients receiving oral decongestants should be monitored for blood pressure changes 5. Use with extreme caution or avoid in patients with:
- Cerebrovascular or cardiovascular disease
- Hyperthyroidism
- Closed-angle glaucoma
- Bladder neck obstruction 5
Drug Interactions
Avoid concomitant use with caffeine and stimulants (such as ADHD medications), as this combination increases adverse events including tachyarrhythmias, insomnia, and hyperactivity 5.
Duration of Treatment
Pseudoephedrine is intended for short-term symptomatic relief only. Multiple dosing for up to 7 days when given as needed for symptom relief has been shown to be generally safe 3, but prolonged use should be avoided. The guideline evidence emphasizes that oral decongestants are effective for temporary relief but should not be used chronically 5.
Common Pitfalls to Avoid
- Do not exceed recommended doses: Higher doses provide no additional benefit and increase cardiovascular risks 2
- Do not combine with other stimulants: This significantly increases risk of adverse events 5
- Do not use in young children: The risk-benefit ratio is unfavorable in children under 6 years 5, 1
- Monitor for side effects: Insomnia, loss of appetite, irritability, and palpitations are common 5; somnolence was reported in 71.9% of children in one study 3